Why wait for St Leger Day
Is the 'sell in May and go away' adage still relevant in today's trading environment? I fear not.
Is the 'sell in May and go away' adage still relevant in today's trading environment? I fear not.
It’s fair to say that investing in equities is no as longer straight-forward as it was last year.
The battle for AstraZeneca between Pfizer, the UK government and the existing shareholders of both companies is, as far as investors are concerned, all about its valuation - nothing more, nothing less.
The FCA's review of the clarity of fund charges shows that there remains a long way to go to a single number that investors can use to compare one fund with another.
Whispers that now is the time to take a fresh look at emerging markets appear to be developing into shouts this week
Innovative, nimble and cheap, ETFs have taken over the investment world by storm with their competitive and innovative offerings.
Interest rates in the EU and the UK remain at historic lows, making life hard and a little riskier for yield seekers.
On 22 May, we will be asked to step up to the ballot box for the European Parliamentary elections; while politicians postulate should investors invest?
Views split on whether recent spate of big name M&A will develop into a sustained and broad recovery in dealmaking
Few contrarians are willing to put a gun to their head in what is appearing to be a game of Russian stock market roulette.
The nature of historically low interest rates is that the only way is up, but which central bank will make the first move, and when, is a matter of fierce debate.
As we move into markets driven more by company fundamentals and less by momentum and froth, it provides much more of an opportunity for true bottom-up stock pickers to showcase their talents.